| Schedule of extension warrants issued to affiliates |
Between September 22,
2014, and August 16, 2016, the Company raised an aggregate principal amount of $6.0 million in Notes, which along with of $317,000
of interest thereon, were converted on September 21, 2016 into 1,263,406 shares of Common Stock at $5.00 per share. Of the $6.0
million of Notes sold by the Company, $5.3 million were purchased by directors, an officer and greater than 5% shareholders of
the Company and converted into shares as follows.
| |
|
|
|
Principal Investment
in Convertible Notes |
|
|
Interest Earned
At conversion |
|
|
Shares Issued
on conversion |
|
| RSJ |
|
(1) |
|
$ |
2,100,000 |
|
|
|
122,200 |
|
|
|
444,454 |
|
| John Pappajohn |
|
(2) |
|
|
1,600,000 |
|
|
|
52,500 |
|
|
|
290,498 |
|
| Tierney Family Trust |
|
(3) |
|
|
640,000 |
|
|
|
46,600 |
|
|
|
137,328 |
|
| Follman Family Trust |
|
(4) |
|
|
550,000 |
|
|
|
20,400 |
|
|
|
114,074 |
|
| Robin Smith MD |
|
(5) |
|
|
100,000 |
|
|
|
3,900 |
|
|
|
20,776 |
|
| Geoffrey Harris |
|
(6) |
|
|
10,000 |
|
|
|
300 |
|
|
|
2,058 |
|
| George Carpenter |
|
(7) |
|
|
100,000 |
|
|
|
1,300 |
|
|
|
20,254 |
|
| Oman Ventures |
|
(8) |
|
|
200,000 |
|
|
|
20,400 |
|
|
|
44,089 |
|
| |
|
|
|
$ |
5,300,000 |
|
|
|
267,600 |
|
|
|
1,073,531 |
|
| |
(1) |
RSJ is a greater
than 10% shareholder. Michal Votruba, a Director for Life Sciences for the RSJ/Gradus Fund, joined our Board on July 30, 2015. |
| |
(2) |
John Pappajohn is a member of the Board. He purchased $1,600,000 of Notes of which $200,000 were assigned to four accredited investors on September 6, 2015. Approximately $10,400 of the total interest was attributable to such transferred Notes, resulting in an aggregate of 42,084 shares being issued upon the conversion of such transferred Notes. |
| |
(3) |
Thomas Tierney is a trustee of the Tierney Family Trust. Mr. Tierney originally joined the Board on February 25, 2013 and served as Chairman of the Board from March 26, 2013 through his resignation on May 22, 2015. On September 29, 2016 Mr. Tierney rejoined the Board. The Tierney Family Trust is a greater than 5% shareholder of the Company. |
| |
(4) |
Robert Follman is a trustee of the Follman Family Trust and is a member of the Board. |
| |
(5) |
Dr. Robin Smith is the Chairman of the Board. |
| |
(6) |
Geoffrey Harris is a member of the Board and Chairman of the Audit Committee. |
| |
(7) |
George Carpenter is the CEO of the Company. |
| |
(8) |
Mark & Jill Oman are the beneficial owners of Oman Ventures and were greater than 5% shareholders of the Company. |
|